Total current assets Total assets Total current liabilities Total liabilities Total stockholders’ equity Balance Balance Total liabilities and stockholders’ equity Total operating expenses Loss from continuing operations Other income (expense), net Loss from continuing operations before income taxes Loss from continuing operations Operations, and incurred a net loss Net loss Net Loss Net loss Comprehensive loss Balance (in Shares) Balance (in Shares) Common stock, shares outstanding Equity Components [Axis] Net cash flows from operating activities Operations Net cash flows from financing activities Net Change in Cash Cash, Beginning of the Period Cash, End of the Period Cash, Beginning of the Period - Discontinued Operations Cash, End of the Period - Discontinued Operations Basis of Presentation [Abstract] Antidilutive Securities [Axis] Schedule of Deferred Contract Cost Activity [Abstract] Carrying Value at December 31, 2023 Carrying Value at June 30, 2024 Other Current Assets [Abstract] Schedule of Other Current Assets [Abstract] Total other current assets Other current assets, net Intangible Assets, Net (Other than Goodwill) [Abstract] Carrying Value, Beginning Carrying Value, ending Total Carrying Value at June 30, 2024 Intangible Assets, net Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Future Amortization of Intangible Assets [Abstract] Accounts Payable and Accrued Expenses [Abstract] Total Accounts payable and accrued expenses Related Party Transactions [Abstract] Stockholders Equity [Abstract] Class of Warrant or Right [Axis] Number of Shares, Outstanding Weighted Average Exercise Price, Outstanding Statistical Measurement [Axis] Number of Shares, Outstanding Weighted Average Exercise Price, Outstanding Aggregate Intrinsic Value, Outstanding Exercise Price Range [Axis] Commitments and Contingencies [Abstract] Subsequent Event [Abstract] ASSETS Current Assets: Cash Accounts receivable, net Deferred contract costs Contract assets Goodwill LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Deferred revenue Commission liability Accrued severance liability Convertible debt, net Non-current Liabilities: Convertible debt, net Accrued severance liability Commitments and Contingencies (Note 7) Stockholders’ Equity: Common stock, $0.0001 par value, 150,000,000 and 250,000,000 shares authorized; 10,920,851 and 9,450,220 shares issued and outstanding as of June 30, 2024 and December 31, 2023 respectively Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common shares issued Additional paid in capital Accumulated deficit Accumulated comprehensive income Revenues, net Revenue Operating Expenses: General and administrative Research and development Depreciation and amortization Other Income (Expense): Interest income Loss on debt extinguishment Loss on debt extinguishment Gain from discontinued operations Total gain from discontinued operations Net Loss Per Share - Basic and Diluted Continuing operations, Basic (in Dollars per share) Continuing operations, Diluted Discontinued operations, Basic (in Dollars per share) Discontinued operations, Diluted Weighted Average Shares Outstanding - Basic (in Shares) Weighted Average Shares Outstanding – Diluted (in Shares) Foreign currency translation loss Foreign currency translation Stock-based compensation Sale of common stock for cash, net of offering costs Sale of common stock for cash, net of offering costs (in Shares) Stock Issued During Period, Shares, New Issues Cashless stock option exercise Cashless stock option exercise (in Shares) Warrants issued for services Shares issued in lieu of interest Shares issued in lieu of interest (in Shares) Conversion of convertible notes into common stock Conversion of convertible notes into common stock (in Shares) Common stock exchange for Convertible Notes Conversion of credit facility borrowings into common stock Conversion of credit facility borrowings into common stock (in Shares) CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss with cash flows from operations: Stock-based compensation Depreciation and amortization expense Amortization of debt discounts and issuance costs Non-cash recruiting fees Shares issued in lieu of interest Gain from sale of discontinued operation Gain on sale of discontinued operations Conversion expense Conversion expense Changes in operating assets and liabilities: Accounts payable and accrued expenses Deferred revenue Other accrued liabilities Adjustments relating to discontinued operations CASH FLOWS FROM INVESTING ACTIVITIES: Net cash flows from investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from sale of common stock, net of offering costs Gross proceeds (in Dollars) Credit facility drawdown, net of issuance costs Effect of Foreign Currencies Supplemental Disclosure of Cash Flow Information: Cash paid for interest Cash paid for income taxes - discontinued operations Cash paid for income taxes Cash paid for income taxes - discontinued operations Schedule of Non-cash Investing and Financing Activities: Conversion of convertible note payable and accrued interest to common stock Warrants for services with the sale of common stock Cashless option and warrant exercises Interest expense, net Income tax expense Accounts receivable Deferred contract costs Other current assets Purchase of intangible assets Common Stock Common Stock [Member] Additional Paid-in Capital Accumulated Deficit Accumulated Other Comprehensive Income BASIS OF PRESENTATION Schedule of Diluted Loss per Share Total dilutive securities Schedule of Deferred Contract Cost Activity Additions OTHER CURRENT ASSETS Schedule of Other Current Assets Prepaid insurance Prepaid third party services INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL) Schedule of Intangible Assets Useful Lives Additions Cost Schedule of Future Amortization of Intangible Assets 2024 (Remainder of the Year) 2025 2026 2027 2028 Thereafter ACCOUNTS PAYABLE AND ACCRUED EXPENSES Schedule of Accounts Payable and Accrued Expenses Trade payables